Stoppel Laura has filed 5 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 13750 shares of Artiva Biotherapeutics, Inc. ($ARTV) on June 24, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 24, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Stoppel Laura | Not found | A | Director Stock Option (Right to Buy) | 13750 | $0.00 | 13,750.0000 | 24,363,119 | 9999.99% | 0.06% |
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Stoppel Laura | Director | A | Common Stock | 12800 | $0.00 | 12,800.0000 | 60,573,425 | 9999.99% | 0.02% |
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Stoppel Laura | Director | A | Stock Option (right to buy) | 19500 | $0.00 | 19,500.0000 | 60,573,425 | 9999.99% | 0.03% |
| June 10, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | Stoppel Laura | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Stoppel Laura | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |